Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms
The DOI matches its Crossref record; 257 of the 257 references it cites were found in a registry or an index.
Abstract
Increasing evidence demonstrates that neuroplasticity, a fundamental mechanism of neuronal adaptation, is disrupted in mood disorders and in animal models of stress. Here we provide an overview of the evidence that chronic stress, which can precipitate or exacerbate depression, disrupts neuroplasticity, while antidepressant treatment produces opposing effects and can enhance neuroplasticity. We discuss neuroplasticity at different levels: structural plasticity (such as plastic changes in spine and dendrite morphology as well as adult neurogenesis), functional synaptic plasticity, and the molecular and cellular mechanisms accompanying such changes. Together, these studies elucidate mechanisms that may contribute to the pathophysiology of depression. Greater appreciation of the convergence of mechanisms between stress, depression, and neuroplasticity is likely to lead to the identification of novel targets for more efficacious treatments.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“current evidence indicates that impairment in growth factor signaling is associated with depressed mood (Pittenger and Duman 2008).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Pittenger and Duman 2008
In the citing paper
“neurotrophic growth factors and related signaling pathways constitute major players in neuroplasticity”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Pittenger and Duman 2008
In the citing paper
“In addition, clean-cut evidence shows that antidepressants require neuroplasticity pathways to rescue the observed deficits in neuronal and synaptic plasticity often associated with mood disorders (Pittenger and Duman 2008).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Pittenger and Duman 2008
In the citing paper
“While traditional antidepressants acutely increase synaptic levels of monoamines, their chronic administration leads to changes in structural neuroplasticity that are contemporaneous with their clinical therapeutic effects (10–12).”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [10]
In the citing paper
“these changes in neural circuitry are believed to underlie the deficits in learning/memory, mood, motivation, and reward seeking that are characteristic of depression and related disorders (10, 67–74)”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [10]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120 · cited 1×
“The relationship between psychosocial stressors and the development of depression in susceptible individuals has long been apparent (Kendler et al, 1999; Caspi et al, 2003).”
BackgroundNeurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369
The Organization of Behavior; A Neuropsychological Theory.
Attneave, F., B., M., & Hebb, D. O. (1950) · The American Journal of Psychology · doi:10.2307/1418888 · Cited by 5,146
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 1×
“As neurogenesis appears to be required for the behavioral response to antidepressants in rodents (Santarelli et al, 2003; see below) and impaired neurogenesis has been hypothesized to represent a core pathophysiological feature of major depression (Duman, 2004), this effect represents yet another…”
BackgroundSelf-citationThe Organization of Behavior: A Neuropsychological Theory
(1950) · Journal of the American Medical Association · doi:10.1001/jama.1950.02910470083028 · Cited by 4,195
Malenka, R. C., & Bear, M. F. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.012 · Cited by 3,968
The molecular biology of memory storage: a dialogue between genes and synapses
Kandel, E. R. (2001) · Science · doi:10.1126/science.1067020 · Cited by 3,917 · cited 2×
“CREB, and other inducible transcription factors, induce effector genes that contribute to the stabilization of synaptic plasticity (Kandel, 2001).”
BackgroundEgan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Research works printed but not linked: 3
- American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders (DSM) IV-TR. American Psychiatric Press: Washington, DC.
- Nemeroff CB (2006). Use of atypical antipsychotics in refractory depression and anxiety. J Clin Psych 66 (S8): 13–21.
- O'Connor JJ, Rowan MJ, Anwyl R (1993). Naunyn Schmiedebergs Arch. Pharmacology 348: 158–163.
Cited by
Items 301–400 of 1,010
miR-155 as an Important Regulator of Multiple Sclerosis Pathogenesis. A Review
Maciak, K., Dziedzic, A., Miller, E. D., & Saluk, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094332 · Cited by 96
Falowski, S. M., Sharan, A., Reyes, B. A. S., Sikkema, C., Szot, P., & Van Bockstaele, E. J. (2011) · Neurosurgery · doi:10.1227/neu.0b013e3182237346 · Cited by 87
“This finding demonstrates that DBS of the NAcc not only halted the progression of the disease process but improved it, consistent with evidence showing that neuronal adaptation is disrupted in mood disorders and that treatments for depression would need to enhance neuroplasticity.(42) The present study also determines…”
ResultArakawa, S., Shirayama, Y., Fujita, Y., Ishima, T., Horio, M., Muneoka, K. T., Iyo, M., & Hashimoto, K. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.09.008 · Cited by 99
Braithwaite, V. A., & Ebbesson, L. O. E. (2014) · Scientific and Technical Review (World Organisation for Animal Health) · doi:10.20506/rst.33.1.2285 · Cited by 102
Emon, M. P. Z., Das, R., Nishuty, N. L., Shalahuddin Qusar, M. M. A., Bhuiyan, M. A., & Islam, M. R. (2020) · BMC Research Notes · doi:10.1186/s13104-020-04952-3 · Cited by 85
Regulation of glycogen synthase kinase‐3 during bipolar mania treatment
Li, X., Liu, M., Cai, Z., Wang, G., & Li, X. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00866.x · Cited by 87
“The pathophysiological mechanisms underlying bipolar disorder are unknown, but may include genetic variations, abnormal development of neural networks, and dysregulation of neurotransmitters and signaling activities (4-6).”
BackgroundNeuropeptides in depression: Role of VGF
Thakker-Varia, S., & Alder, J. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.006 · Cited by 86
“These data suggest that BDNF plays opposite roles in the hippocampal-prefrontal network and mesolimbic reward pathways [116] and suggest that BDNF signaling in the VTA-nucleus accumbens (NAc) pathway is important for forming memories of rewarding and negative stimuli [117].”
BackgroundInfluentialMiller, B. H., Schultz, L. E., Gulati, A., Su, A. I., & Pletcher, M. T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014458 · Cited by 83
“This does not, however, invalidate the many reports that have identified an association between stress and depression in humans, or between chronic stress and behavioral despair in animal models [16,62].”
ResultTakebayashi, M., Hashimoto, R., Hisaoka, K., Okada‐Tsuchioka, M., & Kunugi, H. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0452-1 · Cited by 89
“Recent morphological and histological studies have suggested that there is an organic impairment of the neuron–glia–vascular network in the brain, so called neuroplasticity, and that this impairment is associated with mood disorders (Pittenger and Duman 2008).”
A robust and reliable non-invasive test for stress responsivity in mice
Zimprich, A., Garrett, L., Deussing, J. M., Wotjak, C. T., Fuchs, H., Gailus-Durner, V., de Angelis, M. H., Wurst, W., & Hölter, S. M. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00125 · Cited by 85
Future antidepressant targets: neurotrophic factors and related signaling cascades
Schmidt, H. D., Banasr, M., & Duman, R. S. (2008) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.10.003 · Cited by 93
Self-citationDepressive behavior and activation of the orexin/hypocretin system.
Arendt, D. H., Ronan, P. J., Oliver, K. D., Callahan, L. B., Summers, T. R., & Summers, C. H. (2013) · Behavioral Neuroscience · doi:10.1037/a0031442 · Cited by 95
“Activation of orexin receptors stimulates intracellular calcium influx through a number of intracellular signaling cascades that produce long-term potentiation (LTP; Holmqvist et al., 2005; Lund et al., 2000; Pittenger & Duman, 2008).”
Backgroundde Diego-Adeliño, J., Portella, M. J., Gómez-Ansón, B., López-Moruelo, O., Serra-Blasco, M., Vives, Y., Puigdemont, D., Pérez-Egea, R., Álvarez, E., & Pérez, V. (2013) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110185 · Cited by 86
Otsuka, T., Nishii, A., Amemiya, S., Kubota, N., Nishijima, T., & Kita, I. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.10.055 · Cited by 86
“antidepressant/anxiolytic properties are not clearly understood, previous studies have shown that monoaminergic hypofunction, especially in the central serotonergic system, is implicated in the pathophysiology of anxiety and depression [1,41,42].”
Wu, T.-C., Chen, H.-T., Chang, H.-Y., Yang, C., Hsiao, M., Cheng, M., & Chen, J. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.09.011 · Cited by 96
“, 2000), chronic intense stress has been recognized as one of the crucial components in the emergence of major depression (McEwen, 2007; Pittenger and Duman, 2008).”
BackgroundYazır, Y., Utkan, T., Gacar, N., & Arıcıoğlu, F. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.10.010 · Cited by 90
“Chronic stress is an unavoidable life experience that can induce depression [1], impair spatial cognition [2], and cause abnormalities in neuroendocrine function [3] and plasticity [4].”
Sun, Y., Blumberger, D. M., Mulsant, B. H., Rajji, T. K., Fitzgerald, P. B., Barr, M. S., Downar, J., Wong, W., Farzan, F., & Daskalakis, Z. J. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0302-8 · Cited by 85
Aleksandrova, L. R., Wang, Y. T., & Phillips, A. G. (2020) · Molecular Brain · doi:10.1186/s13041-020-00627-z · Cited by 85
The GABABreceptor as a target for antidepressant drug action
Ghose, S., Winter, M. K., McCarson, K. E., Tamminga, C. A., & Enna, S. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01004.x · Cited by 86
“, 2009), it is possible that alterations in GABAB receptor expression and function influences hippocampal neurogenesis, which may be a component of the clinical response to antidepressants (Pittenger and Duman, 2008).”
BackgroundInfluentialBlood mononuclear cell gene expression signature of postpartum depression
Segman, R. H., Goltser‐Dubner, T., Weiner, I., Canetti, L., Galili‐Weisstub, E., Milwidsky, A., Pablov, V., Friedman, N., & Hochner‐Celnikier, D. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.65 · Cited by 92
In vitro inhibition of mitochondrial respiratory rate by antidepressants
Hroudová, J., & Fišar, Z. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.07.017 · Cited by 85
“On the basis of observations that mitochondrial dysfunction induces activation of gene expression through the transcription factor, cAMP response element-binding protein (CREB) via the cAMP signaling pathway (Arnould et al., 2002) and that effects of long-term treatment with antidepressants are linked to the activatio…”
MethodPharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications
Fabbri, C., & Serretti, A. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0594-9 · Cited by 84
Abera, M., Hanlon, C., Daniel, B., Tesfaye, M., Workicho, A., Girma, T., Wibæk, R., Andersen, G. S., Fewtrell, M. S., Filteau, S., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0278432 · Cited by 101
“Stress-induced glucocorticoid in the brain interferes with normal neurogenesis and synaptic plasticity leading to impaired functions of the nervous system which can result in mental illness [9–11].”
BackgroundAtomoxetine acts as an NMDA receptor blocker in clinically relevant concentrations
Ludolph, A. G., Udvardi, P. T., Schaz, U., Henes, C., Adolph, O., Weigt, H. U., Fegert, J. M., Boeckers, T. M., & Föhr, K. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00707.x · Cited by 82
“Antidepressants have previously been shown to modulate glutamatergic neurotransmission, a mechanism that presumably contributes to the antidepressant effect (reviewed in Pittenger and Duman, 2008).”
BackgroundLeptin Induces Hippocampal Synaptogenesis via CREB-Regulated MicroRNA-132 Suppression of p250GAP
Dhar, M., Zhu, M., Impey, S., Lambert, T. J., Bland, T., Karatsoreos, I. N., Nakazawa, T., Appleyard, S. M., & Wayman, G. A. (2014) · Molecular Endocrinology · doi:10.1210/me.2013-1332 · Cited by 83
Guo, M., Lu, Y., Garza, J. C., Li, Y., Chua, S. C., Zhang, W., Lu, B., & Lu, X.-Y. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.9 · Cited by 83
Zheng, X., Cheng, Y., Chen, Y., Yue, Y., Li, Y., Xia, S., Li, Y., Deng, H., Zhang, J., & Cao, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030493 · Cited by 87
“In addition, stress hormones can cross the placental barrier and potentially result in permanent adverse short- and long-term neuroanatomical, biological, behavioral and immune modifications in the offspring [27,28].”
BackgroundRéus, G. Z., Abelaira, H. M., Stringari, R. B., Fries, G. R., Kapczinski, F., & Quevedo, J. (2012) · Metabolic Brain Disease · doi:10.1007/s11011-012-9281-2 · Cited by 81
“In contrast, antidepressants drugs induce an increase in BDNF levels in humans and animals (Pittenger and Duman 2008).”
BackgroundThe pharmacological properties of antidepressants
Racagni, G., & Popoli, M. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3283311acd · Cited by 83
“…adaptations (regulation of intracellular signal transduction pathways and expression of specific target genes) that underlie the therapeutic actions of antidepressants (Wong and Licinio, 2001; Nestler et al., 2002; Tardito et al., 2006; Krishnan and Nestler, 2008; Pittenger and Duman, 2008).”
BackgroundImpact of glucocorticoids on brain function: Relevance for mood disorders
Joëls, M. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.03.004 · Cited by 94
“This has been most extensively studied with respect to neurogenesis (Czéh et al., 2001; Santarelli et al., 2003; Drew and Hen, 2007; Pittenger and Duman, 2008).”
BackgroundMilne, A. M., MacQUEEN, G. M., Yücel, K., Soreni, N., & Hall, G. B. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.03.031 · Cited by 93
“…factors such as brain derived neurotrophic factor resulting in decreased neurogenesis, increased remodeling of dendrites, loss of glial cells, or increased excitotoxicity, could lead to low HC volume and vulnerability to subsequent episodes of depression, (McEwen, 1999; Pittenger and Duman, 2008).”
Zoladz, P. R., Park, C. R., Halonen, J. D., Salim, S., Alzoubi, K. H., Srivareerat, M., Fleshner, M., Alkadhi, K. A., & Diamond, D. M. (2012) · Hippocampus · doi:10.1002/hipo.20922 · Cited by 80
Neuroinflammatory basis of depression: learning from experimental models
Afridi, R., & Suk, K. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.691067 · Cited by 82
“Moreover, deficits in synaptic plasticity induced by altered glutamatergic neurotransmission are involved in depression pathology, constituting the “neuroplasticity” hypothesis of depression (Pittenger and Duman, 2008).”
BackgroundPlasma BDNF levels vary in relation to body weight in females
Pillai, A., Bruno, D., Sarreal, A. S., Hernando, R. T., Saint-Louis, L. A., Nierenberg, J., Ginsberg, S. D., Pomara, N., Mehta, P. D., Zetterberg, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039358 · Cited by 82
“BDNF regulates the development and plasticity of neural circuits involved in mood disorders such as depression [3].”
BackgroundBarthas, F., Humo, M., Gilsbach, R., Waltisperger, E., Karatas, M., Leman, S., Hein, L., Belzung, C., Boutillier, A., Barrot, M., et al. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.01.019 · Cited by 87
Lee, E.-H., Park, J.-Y., Kwon, H.-J., & Han, P.-L. (2021) · Nature Communications · doi:10.1038/s41467-021-26968-4 · Cited by 82
Jemni, M., Zaman, R., Carrick, F. R., Clarke, N. D., Marina, M., Bottoms, L. M., Matharoo, J. S., Ramsbottom, R., Hoffman, N., Groves, S. J., et al. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1102526 · Cited by 93
“Disruptions in neuroplasticity pathways may contribute to the pathophysiology of depression (Pittenger and Duman, 2008).”
BackgroundNowacka-Chmielewska, M. M., & Obuchowicz, E. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71031-4 · Cited by 89
“This process can be up- or down-regulated by various neuroendocrine, environmental or pharmacological factors [40, 71].”
BackgroundEndocannabinoid Signaling in the Etiology and Treatment of Major Depressive Illness
Hillard, C., & Liu, Q.-S. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660735 · Cited by 78
“Chronic treatment with effective anti-depressant drugs, repeated ECT and voluntary exercise all increase neurogenesis in the hippocampus, evidence that reduced neurogenesis could contribute to depression [148].”
BackgroundNeurobiological, Cognitive, and Emotional Mechanisms in Melodic Intonation Therapy
Merrett, D. L., Peretz, I., & Wilson, S. J. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00401 · Cited by 88
Sebastião, A. M., & Ribeiro, J. A. (2014) · Brain Research · doi:10.1016/j.brainres.2014.11.008 · Cited by 86
Ma, K., Guo, L., Xu, A., Cui, S., & Wang, J.-H. (2016) · PLOS ONE · doi:10.1371/journal.pone.0159093 · Cited by 84
Li, Y., Pehrson, A. L., Waller, J. A., Dale, E., Sánchez, C., & Gulinello, M. E. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00279 · Cited by 84
“Importantly, in addition to a relationship between neuroplasticity and cognitive function, emerging hypotheses on the mechanistic basis for mood dysfunction also prominently feature disturbances in neuroplasticity (Pittenger and Duman, 2008).”
BackgroundHeart and soul: heart rate variability and major depression
Kidwell, M., & Ellenbroek, B. A. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000387 · Cited by 86
“Reduced neuroplasticity has been shown to be implicated in depression (Pittenger and Duman, 2008; Eyre and Baune, 2012; Player et al., 2013), and while the exact mechanisms are beyond the scope of this paper, VNS, like antidepressants (D’sa and Duman, 2002), has been suggested to improve neuroplasticity in depressed i…”
BackgroundDuan, W., Cao, D., Wang, S., & Cheng, J. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00375 · Cited by 85
Jayatissa, M. N., Henningsen, K., West, M. J., & Wiborg, O. (2009) · Brain Research · doi:10.1016/j.brainres.2009.07.001 · Cited by 85
Huang, R., Hu, W., Yin, Y., Wang, Y., Li, W., & Li, W. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.2026 · Cited by 87
“Chronic stress has been reported to be associated with many neurodegenerative diseases, such as depression, AD and Parkinson's disease (22-24).”
Page, C. E., Epperson, C. N., Novick, A. M., Duffy, K. A., & Thompson, S. M. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02625-2 · Cited by 80
“…changes and increased expression of BNDF, can occur downstream of dopamine and norepinephrine receptors as well as serotonin receptors, suggesting that enhanced signaling of these monoamines is relevant to the neuroplastic effects of antidepressants as well (reviewed in Pittenger and Duman [21]).”
Effects of chronic mild stress on behavioral and neurobiological parameters — Role of glucocorticoid
Chen, J., Wang, Z., Zuo, W., Zhang, S., Chu, S., & Chen, N. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.11.006 · Cited by 84
Müller, H. K., Wegener, G., Popoli, M., & Elfving, B. (2011) · Brain Research · doi:10.1016/j.brainres.2011.02.048 · Cited by 87
“(Pittenger and Duman, 2008).”
Heiser, J. H., Schuwald, A. M., Sillani, G., Ye, L., Müller, W. E., & Leuner, K. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12376 · Cited by 87
The alteration of hypoxia inducible factor-1 (HIF-1) and its target genes in mood disorder patients
Shibata, T., Yamagata, H., Uchida, S., Otsuki, K., Hobara, T., Higuchi, F., Abe, N., & Watanabe, Y. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.01.003 · Cited by 88
“…an adaptation that encompasses both functional and structural changes to protect neurons against various stimulations, and recent studies have suggested that the dysfunctionof neural plasticity is associated with mood disorders (Duman, 2004; Krishnan and Nestler, 2008; Pittenger and Duman, 2008).”
BackgroundAgomelatine, a novel intriguing antidepressant option enhancing neuroplasticity: A critical review
Pompili, M., Serafini, G., Innamorati, M., Venturini, P., Fusar-Poli, P., Sher, L., Amore, M., & Girardi, P. (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.765593 · Cited by 78
“Also, agomelatine may promote neurogenesis and enhance levels of brain-derived neurotrophic factor in the hippocampus (Manji et al. 2003; Pittenger and Duman 2008; Reznikov et al. 2009; Soumier et al. 2009).”
BackgroundThe protective effects of Ghrelin/GHSR on hippocampal neurogenesis in CUMS mice
Huang, H., Chen, X., Han, Q.-Q., Wang, J., Pilot, A., Yu, R., Liu, Q., Li, B., Wu, G.-C., Wang, Y., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.05.013 · Cited by 83
Pallavi, P., Sagar, R., Mehta, M., Sharma, S., Subramanian, A., Shamshi, F., Sengupta, U., Qadri, R., Pandey, R. M., & Mukhopadhyay, A. K. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.04.033 · Cited by 88
“etiopathogenesis of depression since plasticity orders the base-line neurosynaptic support for various mood and depressive disorders (Pittenger and Duman, 2008).”
BackgroundSarro, E. C., Sullivan, R. M., & Barr, G. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2013.10.064 · Cited by 77
“…results supplement a body of literature using chronic unpredictable or variable stress as one of the most clinically relevant stress paradigms in the rodent, in that it produces many of the behavioral profiles observed in patients with anxiety and related mood disorders (Pittenger and Duman, 2008).”
BackgroundResultGoldstein, J. M., Handa, R. J., & Tobet, S. A. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.12.001 · Cited by 77
“pocampus, and implicated in the etiology of MDD (Schumacher et al., 2005; Martinowich et al., 2007; Pittenger and Duman, 2007).”
Hansson, A. C., Nixon, K., Rimondini, R., Damadzic, R., Sommer, W. H., Eskay, R., Crews, F. T., & Heilig, M. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000246 · Cited by 77
“Finally, stimulation of hippocampal neurogenesis has been postulated as a therapeutic mechanism behind antidepressant actions (Duman & Monteggia, 2006; Malberg et al. 2000; Pittenger & Duman, 2008; Santarelli et al. 2003).”
BackgroundNegrón-Oyarzo, I., Aboitiz, F., & Fuentealba, P. (2016) · Neural Plasticity · doi:10.1155/2016/7539065 · Cited by 75
Park, J.-Y., You, J.-S., & Chang, K.-J. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-s1-s40 · Cited by 79
“The stress situation can cause or aggravate depression [10], and adolescent girls respond to general stressors with greater depression [11].”
BackgroundCastilla‐Ortega, E., Hoyo-Becerra, C., Pedraza, C., Chun, J. J. M., de Fonseca, F. R., Estivill‐Torrús, G., & Santín, L. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025522 · Cited by 90
“Repeated stress is frequent in our society, and its pathological consequences on the hippocampus are extensive and cause emotional and cognitive alterations by impairing adult hippocampal neurogenesis [10,20,97,103,104].”
BackgroundAcute stress impairs set-shifting but not reversal learning
Butts, K. A., Floresco, S. B., & Phillips, A. G. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.06.007 · Cited by 77
Kang, M. J. Y., Hawken, E., & Vazquez, G. H. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.860882 · Cited by 77
Melatonin and Depression: A Translational Perspective From Animal Models to Clinical Studies
Tonon, A. C., Pilz, L. K., Markus, R. P., Hidalgo, M. P. L., & Elisabetsky, E. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.638981 · Cited by 90
Chen, C., & Nakagawa, S. (2023) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/171565 · Cited by 83
Yin, Y., Liu, J., Fan, Q.-C., Zhao, S., Wu, X., Wang, J., Liu, Y., Li, Y., & Lu, W. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02638-5 · Cited by 90
“Increasing evidence showed that neuroplasticity would be disrupted under chronic stress, and then depression and cognitive impairment would be precipitated and exacerbated [62].”
BackgroundMajor Depression: A Role for Hippocampal Neurogenesis?
Lee, M. M., Reif, A., & Schmitt, A. G. (2012) · Current topics in behavioral neurosciences · doi:10.1007/7854_2012_226 · Cited by 87
“…are traumatic life events and early life stress such as childhood maltreatment which are often found to be a key component in the life history of patients with mood disorders such as post-traumatic stress-disorder and major depression (Smith 2005; Pittenger and Duman 2008; Teicher et al. 2012).”
BackgroundInfluentialBreeding of tomorrow’s chickens to improve well-being
Cheng, H. W. (2010) · Poultry Science · doi:10.3382/ps.2009-00361 · Cited by 89
“cation of the strength of synaptic transmission) to a given environmental challenge, which in turn adjusts subsequent movement, thoughts, feelings, and behavior (Kasper and McEwen, 2008; Pittenger and Duman, 2008; Calabrese et al., 2009; Maleszka et al., 2009).”
BackgroundZhen, J., Chang, Y.-N., Qu, Z., Fu, T., Liu, J., & Wang, W. (2016) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.02.001 · Cited by 80
“Brain-derived neurotrophic factor transcription is induced by activation of PKA/CREB signaling, and stimulus-dependent induction of BDNF in the hippocampus is essential for long-term potentiation [35] as well as neuronal survival and dendritic growth [36].”
Elevation of p11 in lateral habenula mediates depression-like behavior
Seo, J.-S., Zhong, P., Liu, A., Yan, Z., & Greengard, P. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.96 · Cited by 78
Pathobiological targets of depression
Chopra, K., Kumar, B., & Kuhad, A. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.553603 · Cited by 76
“Epidemiological evidence supports a role for stress as a strong risk factor both for depression [4].”
BackgroundHaim, A., Sherer, M., & Leuner, B. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12752 · Cited by 76
“…and NAc represent critical components of the neural circuitry regulating emotion (Puglisi-Allegra & Ventura, 2012; Volman et al., 2013) and altered structural plasticity in these regions has been linked to depressive behavior in rodents and humans (Pittenger & Duman, 2008; Russo & Nestler, 2013).”
BackgroundKrystal, J. H., Tolin, D. F., Sanacora, G., Castner, S. A., Williams, G. V., Aikins, D. E., Hoffman, R. E., & D'Souza, D. C. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.05.002 · Cited by 76
“However, a number of recent reviews indicate that psychiatric disorders are, themselves, disorders of neuroplasticity [1–4], suggesting that the efficacy of current treatments may be limited by neuroplasticity abnormalities.”
Role of dopamine D2 receptors in plasticity of stress-induced addictive behaviours
Sim, H.-R., Choi, T.-Y., Lee, H. J., Kang, E. Y., Yoon, S., Han, P., Choi, S., & Baik, J. (2013) · Nature Communications · doi:10.1038/ncomms2598 · Cited by 83
The potential role of neuropathic mechanisms in dry eye syndromes
McMonnies, C. W. (2016) · Journal of Optometry · doi:10.1016/j.optom.2016.06.002 · Cited by 81
“Chronic stress can precipitate or exacerbate depression as well as disrupt neuroplasticity.(45) These responses to chronic stress can be countered by anti-depressant treatment.”
InfluentialBiomarkers for Depression: Recent Insights, Current Challenges and Future Prospects
Strawbridge, R., Young, A. H., & Cleare, A. J. (2018) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.16206 · Cited by 78
“134 Neurobiologically, the HPA axis 129 and neurotrophic systems 135 are likely to play a key role in this relationship.”
Cuccurazzu, B., Bortolotto, V., Valente, M. M., Ubezio, F., Koverech, A., Canonico, P. L., & Grilli, M. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.121 · Cited by 85
NPY and its involvement in axon guidance, neurogenesis, and feeding
Hökfelt, T. G. M., Stanić, D., Sanford, S. D., Gatlin, J. C., Nilsson, I. A. K., Paratcha, G., Ledda, F., Fetissov, S. O., Lindfors, C., Herzog, H., et al. (2008) · Nutrition · doi:10.1016/j.nut.2008.06.010 · Cited by 79
Elevated serum levels of FGF-2, NGF and IGF-1 in patients with manic episode of bipolar disorder
Liu, X., Zhang, T., Shen, H., Hong, B., Chen, Z., Peng, D., Wu, Y., Wen, H., Lin, Z., Fang, Y., et al. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.03.042 · Cited by 84
“Recent studies have demonstrated that there are impairments of neuron–glia–vascular network in the brain, so called neuroplasticity, and that these impairments are associated with mood disorders (Pittenger and Duman, 2008).”
BackgroundAnimal models of suicide-trait-related behaviors
Malkesman, O., Pine, D. S., Tragon, T. R., Austin, D. R., Henter, I. D., Chen, G., & Manji, H. K. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.01.004 · Cited by 83
A two-factor model of relapse/recurrence vulnerability in unipolar depression
Farb, N. A. S., Irving, J. A., Anderson, A. K., & Segal, Z. V. (2015) · Journal of Abnormal Psychology · doi:10.1037/abn0000031 · Cited by 75
“Conversely , once such schemas supersede the optimistic elaborative biases observed in healthy individuals, dysphoric elaboration supports attentional capture by schema-congruent depressive events, reducing the plasticity of the representational system (Pittenger & Duman, 2008).”
O’Leary, O. F., Wu, X., & Ċastrén, E. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.09.015 · Cited by 79
“The neural mechanisms underlying the delayed clinical effects of antidepressant drug treatment are still unresolved, but it has been suggested that antidepressants initiate a process involving neuronal plasticity and network reorganization, which over time leads to mood recovery (Charney and Manji, 2004; Castren, 2005…”
BackgroundLeuner, K., Li, W., Amaral, M. D., Rudolph, S., Calfa, G. D., Schuwald, A. M., Harteneck, C., Inoue, T., & Pozzo‐Miller, L. D. (2012) · Hippocampus · doi:10.1002/hipo.22052 · Cited by 86
New Treatment Strategies of Depression: Based on Mechanisms Related to Neuroplasticity
Huang, Y.-J., Lane, H.-Y., & Lin, C.-H. (2017) · Neural Plasticity · doi:10.1155/2017/4605971 · Cited by 74
Leschik, J., Lutz, B., & Gentile, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147339 · Cited by 82
Rodriguez‐Porcel, F., Green, D., Khatri, N., Harris, S. S., May, W. L., Lin, R. C. S., & Paul, I. A. (2011) · The Anatomical Record · doi:10.1002/ar.21402 · Cited by 72
“…monoaminergic targets, this suggests that a target downstream from the synapse, such as the regulation of glutamatergic signaling or synaptic plasticity that is produced by the antidepressant class of drugs (Pittenger and Duman, 2008) might better account for their effects on these behaviors.”
BackgroundFidalgo, T. M., Morales-Quezada, J. L., Muzy, G. S. C., Chiavetta, N. M., Mendonca, M. E., Santana, M. V. B., Goncalves, O. F., Brunoni, A. R., & Fregni, F. (2014) · The Journal of ECT · doi:10.1097/yct.0b013e31828b34d8 · Cited by 71
“The main finding was that BDNF levels in the blood increased if depression was treated with rTMS and antidepressants, suggesting that BDNF levels in patients with MDD are associated with changes in neuroplasticity(76); modulation of BDNF levels and downstream of its signaling can be considered a stressor that might le…”
BackgroundEriksson, T. M., Delagrange, P., Spedding, M., Popoli, M., Mathé, A. A., Ögren, S. O., & Svenningsson, P. (2012) · Molecular Psychiatry · doi:10.1038/mp.2010.131 · Cited by 73
Law, A. J., Pei, Q., Walker, M., Gordon-Andrews, H., Weickert, C. S., Feldon, J., Pryce, C. R., & Harrison, P. J. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.106 · Cited by 74
“…in the hypothalamopituitary-adrenal (HPA) axis (Sapolsky, 2000; Gunnar and Quevedo, 2007), the serotonin (5-HT) system (Gartside et al, 2003; Ichise et al, 2006), neurotrophins (Duman et al, 1997), and synaptic plasticity (Manji et al, 2001; Nestler et al, 2002; Pittenger and Duman, 2008).”
BackgroundStringham, N. T., Holmes, P. V., & Stringham, J. M. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.112650 · Cited by 79
MiR-335 is involved in major depression disorder and antidepressant treatment through targeting GRM4
Li, J., Meng, H., Cao, W., & Qiu, T. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.08.038 · Cited by 73
Plasticity of defensive behavior and fear in early development
Wiedenmayer, C. P. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.11.004 · Cited by 71
“…processes, early aversive experience and learning about a traumatic event can all contribute to an impaired neurobehavioral development that results in pathological fear, anxiety and depression (Grossman et al., 2003; Leonardo and Hen, 2008; Pittenger and Duman, 2008; Tsankova et al., 2007).”
BackgroundAnxiolytic function of the orexin 2/hypocretin A receptor in the basolateral amygdala
Arendt, D. H., Hassell, J., Li, H., Achua, J. K., Guarnieri, D. J., DiLeone, R. J., Ronan, P. J., & Summers, C. H. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.10.010 · Cited by 72
“The neural systems associated with these behaviors are also often affected by disorders such as anxiety and depression (Krishnan and Nestler, 2010; Pittenger and Duman, 2008; Ressler and Mayberg, 2007; Yehuda et al., 1996).”
Drugs related to monoamine oxidase activity
Fišar, Z. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.02.012 · Cited by 78
“The neurotrophic hypothesis of depression (Duman et al., 1997; Duman, 2002; Einat and Manji, 2006; Zarate et al., 2006; Pittenger and Duman, 2008) states that a deficiency in neurotrophic support may contribute to hippocampal pathology during the development of depression and that the reversal of…”
BackgroundKrass, M., Wegener, G., Vasar, E., & Volke, V. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.11.027 · Cited by 73
Mood Disorders Are Glial Disorders: Evidence from In Vivo Studies
Schroeter, M. L., Abdul-Khaliq, H., Sacher, J., Steiner, J., Blasig, I. E., & Mueller, K. (2010) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2010/780645 · Cited by 71
“It has recently been suggested that a loss of neuroplasticity and cellular resilience may underlie the pathophysiology of mood disorders and that optimum long-term treatment can only be achieved by early neurotrophic and/or neuroprotective intervention [1, 2].”
BackgroundOptogenetic strategies to investigate neural circuitry engaged by stress
Sparta, D. R., Jennings, J. H., Ung, R. L., & Stuber, G. D. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.05.007 · Cited by 72
Glutamate normalization with ECT treatment response in major depression
Zhang, J., Narr, K. L., Woods, R. P., Phillips, O. R., Alger, J. R., & Espinoza, R. T. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.46 · Cited by 70
Cattaneo, A., Sesta, A., Calabrese, F., Nielsen, G., Riva, M. A., & Gennarelli, M. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.11 · Cited by 78
“Different peptides with trophic properties, including the neurotrophin BDNF (Pittenger and Duman, 2008; Castrén et al, 2007; Groves, 2007; Kozisek et al, 2008; Calabrese et al, 2007), FGF2 (Turner et al, 2006) and VEGF (Warner-Schmidt and Duman, 2008), have antidepressant activity and their expression is upregulated b…”
InfluentialRusch, H. L., Guardado, P., Baxter, T., Mysliwiec, V., & Gill, J. (2015) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.4770 · Cited by 79
“22,39 Moreover, BDNF is essential for the consolidation of hippocampal-dependent learning; as such, concentration increases may reduce impairments in contextual fear learning, a deficit central to PTSD. 11 Increases in IGF-1 concentrations have additional significance in promoting physical health.”
Metadata
- Authors
- Pittenger, C., & Duman, R. S.
- Affiliations
- Yale University (US)
- Corresponding author
- Duman, Ronald S
- Venue
- Neuropsychopharmacology
- Published
- 2007-09-12
- Volume
- 33
- Issue
- 1
- Pages
- 88-109
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1978891587
- Cited by
- 1,795
- References
- 257
- Citations by year
- 2026: 48 · 2025: 77 · 2024: 83 · 2023: 73 · 2022: 98 · 2021: 137 · 2020: 107 · 2019: 95 · 2018: 97 · 2017: 105 · 2016: 97 · 2015: 99 · 2014: 112 · 2013: 108 · 2012: 147
- FWCI
- 6.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- chronic stress, depression, neuroplasticity, antidepressants, structural plasticity, adult neurogenesis, synaptic plasticity, dendritic spine morphology, mood disorders, animal models of stress, depression pathophysiology
- MeSH terms
- Animals, Depression, Humans, Learning Disabilities, Memory Disorders, Models, Neurological, Neuronal Plasticity, Neurons, Stress, Physiological, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.